CMTM6 and neoplasm: For instance, CMTM6-mediated stabilization of PD-L1 can inhibit the activation of cytotoxic NK cells and impair the antigen-presenting function of dendritic cells, further promoting an immunosuppressive microenvironment conducive to tumor growth and progression (57).